Patent · US Active

Cross-linkers and their uses

US9498541B2 · kind B2 · utility

7Cited by

13References

21Claims

0Family size

Assignee

IMMUNOGEN, INC. · US

Inventors

Ravi V. J. Chari · Newton, US
Robert Yongxin Zhao · Lexington, US
Yelena Kovtun · Stow, US
Rajeeva Singh · Framingham, US
Wayne C. Widdison · Belmont, US

Key dates

Filing date	May 15, 2015
Grant date	Nov 22, 2016
Priority date	—
Expiry date	May 15, 2035

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Charged or pro-charged cross-linking moieties and conjugates of cell binding agents and drugs comprising the charged or pro-charged cross-linking moieties and method of making the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.